Voluntis creates digital companions that empower people to self-manage their treatment in remote collaboration with their health care teams. Dedicated to chronic conditions, Voluntis' products aim to personalize treatment, support team-care coordination and improve real-world outcomes. Voluntis leverages its expertise in digitizing clinical algorithms and its technology platform to design its companion solutions. These include Insulia and Diabeo in diabetes as well as eCO and Zemy in oncology. Voluntis has long-standing partnerships with leading life science companies such as Sanofi, Roche and AstraZeneca. It is a founding member of the Digital Therapeutics Alliance.On July 26th, 2021, AptarGroup acquired a majority stake in Voluntis.78M.
Missing: Voluntis's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Voluntis's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Voluntis
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Voluntis in 3 CB Insights research briefs, most recently on Sep 13, 2021.
Expert Collections containing Voluntis
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Voluntis is included in 10 Expert Collections, including Digital Health.
Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)
HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Voluntis has filed 1 patent.
Telehealth, Health informatics, Software design patterns, Software design, Telemedicine
Telehealth, Health informatics, Software design patterns, Software design, Telemedicine
Latest Voluntis News
Oct 18, 2022
| 2Morrow, Proteus Digital Health, Omada Health News Provided By Share This Article Digital Medicine Market Report PORTLAND, OR, UNITED STATE, October 18, 2022 / EINPresswire.com / -- Allied Market Research added new research on Global Digital Medicine Market - Global Opportunity Analysis and Industry Forecast, 2022–2030. The Digital Medicine market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are 2Morrow Inc., Ginger.io, Inc., Akili Interactive Labs., Livongo Health, AliveCor, Inc., WellDoc, Inc., Mocacare, Proteus Digital Health, Inc., Voluntis and Omada Health. Get Free Sample PDF of Digital Medicine Market Report>>> https://www.alliedmarketresearch.com/request-sample/1671 Which market perspectives are enlightened in the Digital Medicine market report? Executive Summary: It covers a summary of the most vital studies, the Worldwide Digital Medicine market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers. Study Analysis: This covers major players, vital market segments, the scope of the products offered in the Digital Medicine market, the years measured and the study points. Competitive Analysis: In this segment each player is screened based on a products, services, value, SWOT analysis, growth and other significant features. Geographic Analysis: This Digital Medicine market report analyses data on the basis of production, sales, imports & exports, and key players in all regional markets. Digital Medicine Market Segments and Sub-segments:: Digital Medicine Market by Key Players: 2Morrow Inc., Ginger.io, Inc., Akili Interactive Labs., Livongo Health, AliveCor, Inc., WellDoc, Inc., Mocacare, Proteus Digital Health, Inc., Voluntis and Omada Health Digital Medicine Market by Technology: Mobile Health (Applications For Clinical or Assistance In Diagnosis, Remote Monitoring, Reminders And Alters, Healthy Living Application, Productivity Applications, References Applications), EMR/EHR, Telehealth, and Wireless Health Digital Medicine Market by Application: Diabetes, Mental Health, Heart Disease, Smoking, Drug Non-adherence, Obesity, COPD, and Asthma Ask more about Digital Medicine Market Report>>> https://www.alliedmarketresearch.com/purchase-enquiry/1671 Interpretative Tools Used in Market Analysis: The methodical tools including SWOT analysis, Porter’s five forces analysis, and investment return examination were used while breaking down the development of the key players performing in the market. Growth Indicators in the Market: This section of the report covers the indicators that contains mergers & acquisitions, R&D, new product development, joint ventures, and associations of leading participants working in the market. Key Questions Answered: Which are the major regions covered in Digital Medicine Market report? Which is the leading revenue-generating region in Digital Medicine Market? Which is the most influencing segment growing in the Digital Medicine market report? What are the key trends in the Digital Medicine market report? What is the total market value of Digital Medicine market report? Table of Content Chapter Three: Production Market Analysis Chapter Four: Sales Market Analysis Chapter Five: Consumption Market Analysis Chapter Six: Production, Sales and Consumption Market Comparison Analysis Chapter Seven: Major Manufacturers Production and Sales Market Comparison Analysis Chapter Eight: Competition Analysis by Players Chapter Nine: Marketing Channel Analysis Chapter Ten: New Project Investment Feasibility Analysis Chapter Eleven: Manufacturing Cost Analysis Chapter Twelve: Industrial Chain, Sourcing Strategy and Downstream Buyers Thank you for reading the article, Regional reports like North America, Europe, Asia-Pacific, LAMEA are also available. Top Trending Report:- Regenerative Medicine Market Growth Outlook 2022-2030: https://www.alliedmarketresearch.com/regenerative-medicines-market Wearable Patch Market Growth Outlook 2022-2030: https://www.alliedmarketresearch.com/wearable-patch-market-A10358 Dental Implants and Prosthetics Market Growth Outlook 2022-2030: https://www.alliedmarketresearch.com/dental-implants-and-prosthetics-market IVF Devices and Consumables Market Growth Outlook 2022-2030: https://www.alliedmarketresearch.com/In-vitro-Fertilization-Devices-and-Consumables-market About Us: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. David Correa
Voluntis Web Traffic
Voluntis Frequently Asked Questions (FAQ)
When was Voluntis founded?
Voluntis was founded in 2001.
Where is Voluntis's headquarters?
Voluntis's headquarters is located at 22 quai Gallieni, Suresnes.
What is Voluntis's latest funding round?
Voluntis's latest funding round is Corporate Majority - P2P.
How much did Voluntis raise?
Voluntis raised a total of $29M.
Who are the investors of Voluntis?
Investors of Voluntis include AptarGroup, Qualcomm Ventures, Sham Innovation Santé, Karista, Vesalius BioCapital and 7 more.
Who are Voluntis's competitors?
Competitors of Voluntis include Ciba Health, Fitterfly, Sidekick Health, Dr.Diary, Omada Health, Holmusk, Hygieia, Dawn Health, Better Therapeutics, Amalgam Rx and 26 more.
Compare Voluntis to Competitors
SidekickHealth is a gamified health behavior change service that predicts, manages, and prevents chronic and lifestyle-related conditions. SidekickHealth's digital therapeutics software is a social game connecting data from wearable devices and user input, rewarding users for health-improving activities, and is clinically validated with behavioral triggers, economic incentives, and advanced data analytics for health providers, insurers, lifestyle coaches, and employers. It was founded in 2013 and is based in Kopavogur, Iceland.
Omada Health is a digital behavioral medicine company that helps people to change the habits that put them most at risk for serious but largely preventable chronic conditions like heart disease and type 2 diabetes. The company brings behavioral counseling to anyone with an Internet connection, using insights about social networking, gaming, and behavioral science to motivate changes in lifestyle and deliver clinically-meaningful results.
One Drop is a consumer digital health company that has developed One Drop. Available for download for iOS and Apple Watch, One Drop harnesses the power of mobile computing and data science to empower people with diabetes to live healthier lives.
Wellthy Therapeutics is a digital therapeutics (DTx) company that enables individuals to manage and prevent their chronic health conditions. The clinically-validated products are used by pharma and medical device partners as a companion therapy to improve real-world patient outcomes. The DTx suite works as an active digital ingredient beyond the drug, the device, and the insurance policy to improve patient outcomes. The company's active therapeutic areas are in Diabetes, Cardiology, Nephrology, Respiratory, with upcoming therapeutics in development in Women’s Health and Oncology.
WellDoc is a healthcare behavioral science and technology company that focuses on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The flagship product, DiabetesManager, provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence.
Hygieia is a provider of insulin therapy and maker of the d-Nav Insulin Management Program. The d-Nav program includes an AI-powered application that aims to help people with type 2 diabetes use insulin in a safe and effective way to control their blood sugar levels.The company's d-Nav product aims to tell patients exactly how much insulin they need the moment they inject. d-Nav has received FDA-clearance to adjust a medication dose directly to the patient.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.